Study guide

12.1 When New York Law Is Stricter Than Federal Law

New York MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the NY MPJE Exam 1.2 Study Strategy & Federal vs. New York Law Hierarchy

2 Federal Pharmacy Law: Controlled Substances

2.1 Controlled Substances Act & DEA Scheduling 2.2 DEA Registration, Forms & Security 2.3 Federal Food, Drug, and Cosmetic Act (FDCA)

3 Federal Pharmacy Law: Privacy & Supply Chain

3.1 HIPAA & Patient Privacy 3.2 OBRA '90, Medicare/Medicaid & DUR 3.3 DSCSA & Drug Supply Chain Integrity

4 Area 1a: NYSED, Board & Pharmacist Licensure

4.1 NYSED Office of the Professions, Board of Pharmacy & Education Law Article 137 4.2 Pharmacist Licensure: Education, NAPLEX/MPJE & Internship 4.3 License by Endorsement, Renewal & Continuing Education

5 Area 1b: Interns, Technicians & Discipline

5.1 Pharmacy Interns & Limited Permits 5.2 Registered Pharmacy Technicians (RPhT) & Supervision Ratios 5.3 Professional Misconduct, Discipline & Impaired Practitioner Programs

6 Area 2a: Prescribing, Controlled Substances & Collaborative Practice

6.1 Prescription Requirements & Practitioner Authority 6.2 Controlled Substance Prescribing & the NY EPCS Mandate 6.3 Refills & Authority Limitations 6.4 Collaborative Drug Therapy Management (§6801-a) & Non-Patient-Specific Orders

7 Area 2b: Counseling, Immunization & Public Health

7.1 Patient Counseling & Documentation 7.2 Pharmacist Immunization Authority 7.3 Naloxone Access & Public Health Programs 7.4 Patient Confidentiality & Pharmacy Records

8 Area 3a: Verification, Transfers & DUR/I-STOP

8.1 Legitimate Medical Purpose & Corresponding Responsibility 8.2 Prescription Transfers Between Pharmacies 8.3 Prospective DUR & the I-STOP PMP Registry 8.4 Refill Exceptions & Emergency Dispensing

9 Area 3b: Labeling, Packaging & Substitution

9.1 Labeling of Dispensed Drugs 9.2 Packaging: PPPA & Child-Resistant Containers 9.3 Generic Substitution & Interchangeable Biologics (§6816-a) 9.4 OTC, Behind-the-Counter & Restricted Nonprescription Sales

10 Area 4a: Records, Inventories & Delivery

10.1 Ordering, Acquisition & Distribution Records 10.2 Recordkeeping, Storage & Handling 10.3 Controlled Substance Inventories & BNE Registration 10.4 Delivery & Mail-Order Dispensing

11 Area 4b: Compounding, Central Fill & Facilities

11.1 Compounding: Non-Sterile, Sterile & Hazardous Drugs 11.2 Central Fill, Centralized Processing & Shared Pharmacy Services 11.3 Automated Dispensing & Telepharmacy 11.4 Pharmacy Establishment Registration, Inspections & Discipline

12 Test-Day Strategy & Final Review

12.1 When New York Law Is Stricter Than Federal Law 12.2 Test-Day Strategy & Common Traps

12.1 When New York Law Is Stricter Than Federal Law

Key Takeaways Explain This Topic AI

New York mandates electronic prescribing for both controlled and non-controlled substances since March 27, 2016 (Public Health Law § 281) — federal law (21 CFR Part 1311) only permits electronic prescribing of controlled substances and never requires it.

New York limits the written or electronic follow-up on an emergency oral Schedule II prescription to 72 hours (10 NYCRR § 80.68(c)), stricter than the federal 7-day window under 21 CFR § 1306.11(d).

New York limits a Schedule III-V prescription written for more than a 30-day supply to a single refill (10 NYCRR § 80.69(g)), tighter than the federal ceiling of 5 refills within 6 months for Schedules III and IV under 21 CFR § 1306.22.

New York requires personal counseling for new patients, new medications, or dose/route/directions changes, plus a written offer to counsel for off-premises deliveries (8 NYCRR § 63.6), broader than OBRA '90's Medicaid-only counseling mandate.

New York's Public Health Law § 3343-a mandates a PMP registry query before prescribing or dispensing Schedule II-IV controlled substances, and Public Health Law § 3331-a caps an initial acute-pain opioid prescription at a 7-day supply — both topics on which federal law imposes no comparable duty.

Last updated: November 2026

The Stricter-Standard Rule on the NY MPJE

Throughout the exam, whenever New York and federal pharmacy law overlap, the rule is simple: the more restrictive standard controls , and a less restrictive federal floor never displaces a stricter New York ceiling. This is not a New York quirk — it flows from ordinary preemption doctrine. Federal law preempts state law only when Congress says so expressly, occupies the entire regulatory field, or when compliance with both bodies of law is a physical impossibility. Pharmacy practice is traditionally state-regulated, so New York routinely adds duties on top of the federal floor without conflicting with it. On the MPJE, when a stem asks what a pharmacist must do "under New York law" (or simply "in this jurisdiction"), and New York imposes a tighter requirement than federal law, the New York rule is the correct answer — even when a federal-law answer choice is also a true statement.

Reasoning Pattern: Three Questions to Ask

What is the call of the question? Is it asking about federal law, New York law, or "in this jurisdiction" (New York)?

What does each body of law actually require? Recall the federal floor, then the New York rule layered on top of it.

Which is stricter, and does the call ask for the stricter one? If New York adds a duty, restricts a quantity, or shortens a deadline relative to federal law, New York usually supplies the correct answer for a "must do" question.

  • Six Verified Examples of New York Stricter-Than-Federal Rules
  • 1. Mandatory Electronic Prescribing — Broader Than Federal EPCS

Federal law (21 CFR Part 1311) permits electronic prescribing of controlled substances but never requires it. New York goes further in two ways: since March 27, 2016 , under Public Health Law § 281 , practitioners must electronically prescribe both controlled and non-controlled substances (subject to narrow statutory exceptions and a low-volume certification for prescribers issuing 25 or fewer prescriptions in a 12-month period). A paper prescription for a routine antibiotic — not just a controlled substance — can be non-compliant in New York even though federal law never regulated that prescription's transmission method at all.

2. Schedule II Emergency Oral Prescription — 72 Hours, Not 7 Days

Federal law allows a practitioner to phone in an emergency Schedule II prescription and then deliver a signed written or electronic follow-up within 7 days (21 CFR § 1306.11(d)). New York's parallel rule is tighter: under 10 NYCRR § 80.68(c) , the practitioner must deliver the written or electronic follow-up prescription, marked "Authorization for emergency dispensing," within 72 hours of the oral authorization. If the pharmacist receives nothing within that window, the pharmacist must notify the Bureau of Narcotic Enforcement within 7 days of dispensing.

3. Schedule III-V Refill Limit on Large-Quantity Prescriptions

Federal law (21 CFR § 1306.22) allows a Schedule III or IV prescription to be refilled up to 5 times within 6 months (Schedule V refills are as the prescriber authorizes), with no rule tying refill count to the day supply prescribed. New York adds a restriction federal law does not have: under 10 NYCRR § 80.69(g) , if the initial prescription is written for more than a 30-day supply , it may be refilled only once , regardless of how many refills the prescriber authorized on the face of the prescription.

4. Patient Counseling — Beyond OBRA '90's Medicaid-Only Origin

Federal OBRA '90 (42 U.S.C. § 1396r-8(g)) requires a prospective drug utilization review and an offer to counsel, but only for Medicaid outpatients . New York's 8 NYCRR § 63.6 applies to every patient regardless of payer: a pharmacist or pharmacy intern must personally counsel any new patient, any patient receiving a new medication, or any patient with a dose, strength, route, or directions change, documenting any refusal in the pharmacy's records; for prescriptions delivered off-premises (mail or delivery service), §63.6 instead requires a written offer to counsel with a reachable pharmacist's phone number.

5. Mandatory PMP Query for Practitioners — No Federal Counterpart at All

Federal law contains no requirement to query a prescription drug monitoring database before prescribing or dispensing — prescription monitoring programs are entirely creatures of state law. New York's Public Health Law § 3343-a(2) requires practitioners to consult the PMP registry before prescribing or dispensing a Schedule II, III, or IV controlled substance; Schedule V is excluded. Pharmacists are governed separately by § 3343-a(3) : they are authorized, but not required , to consult the registry before dispensing, and may delegate that query to another pharmacist or a pharmacy intern at the same pharmacy. There is no comparably strict federal rule to "beat" here — New York's practitioner mandate exists on a topic federal law is entirely silent on.

6. Seven-Day Limit on Initial Acute-Pain Opioid Prescriptions

Federal law imposes no day-supply ceiling on an opioid prescribed for acute pain. New York's Public Health Law § 3331-a , effective July 22, 2016 , limits a practitioner's initial Schedule II, III, or IV opioid prescription for acute pain to a 7-day supply ; chronic pain, cancer care, hospice, and palliative care are excepted, and any subsequent encounter for the same pain may generate a normal renewal or new prescription.

Topic Federal Floor New York Stricter Rule Citation

E-prescribing Permitted for controlled substances (21 CFR Part 1311) Mandatory for essentially all prescriptions since 3/27/2016 PHL § 281

Emergency oral CII follow-up 7 days (21 CFR § 1306.11(d)) 72 hours 10 NYCRR § 80.68(c)

Schedule III-V refill on >30-day Rx III–IV: up to 5 refills/6 months (21 CFR § 1306.22); V: as authorized; no day-supply trigger Only 1 refill if the initial Rx exceeds a 30-day supply 10 NYCRR § 80.69(g)

Counseling offer Medicaid outpatients only (OBRA '90, 42 U.S.C. § 1396r-8(g)) Personal counseling for every patient on new patient/med/dose change; written offer for off-premises delivery 8 NYCRR § 63.6

PDMP query None Mandatory for practitioners before prescribing/dispensing Schedule II-IV; pharmacists authorized but not required PHL § 3343-a

  • Initial acute-pain opioid None 7-day supply limit PHL § 3331-a
  • Spotting the Pattern on Exam Day

Notice that these six examples fall into two distinct patterns. In examples 1-4, New York and federal law regulate the same topic, and New York simply sets a tighter number or a broader scope. In examples 5-6, federal law is silent — there is no federal rule to compare against, so "New York is stricter" really means "New York imposes a duty federal law never addresses." Both patterns produce the same MPJE answer strategy: when the stem asks what New York law requires, apply the New York-specific rule even if a federal-sounding distractor is technically true of federal law. Never assume federal silence means no duty exists — check whether New York filled the gap.